{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:44:24Z","timestamp":1793054664878,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Triglyceride Glucose (TyG) index has been associated with an increased risk in cardiovascular events. Silent coronary disease is common in patients with type 2 diabetes. In Vietnam, a low-middle income country, the burden of cardiovascular disease is growing simultaneously with the epidemiologic transition. Our aim was to assess the prevalence of coronary stenoses (CS) in patients with type 2 diabetes and no history or symptom of cardiovascular disease and to investigate the association between TyG index and cardiovascular risk factors and both the presence and severity of CS. Futhermore, we assessed the value of TyG index in predicting subclinical CS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional observational study. We recruited 166 patients at Ninh Thuan General Hospital, Vietnam. TyG index and HOMA-IR were calculated, and a coronary computed tomography angiography (CCTA) was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The population was classified according to tertiles of TyG index. The highest TyG values were associated with higher BMI, waist circumference, total cholesterol, LDL-cholesterol, triglycerides, plasma glucose, HbA1c levels and HOMA-IR, lower HDL-cholesterol, a higher incidence of metabolic syndrome and less frequent physical activity (p\u2009&lt;\u20090.05 to\u2009&lt;\u20090.0001). TyG index correlated with logHOMA-IR (p\u2009&lt;\u20090.0001). CS\u2009\u2265\u200950% were present in 60 participants and 32 had coronary artery stenosis\u2009\u2265\u200970%. TyG index and HOMA-IR were significantly higher in patients with CS\u2009\u2265\u200970%. The number of narrowed coronary arteries and the degree of stenosis were associated with higher TyG index levels (p\u2009=\u20090.04 and\u2009&lt;\u20090.005 respectively). A TyG index\u2009\u2265\u200910 was significantly associated with an increased risk of multiple coronary artery disease and of more severe CS. After adjusting for confounding factors, including logHOMA-IR, these risks remained mostly significant. A TyG index threshold at 10 resulted in 57% sensitivity and 75% specificity for predicting the presence of CS\u2009\u2265\u200970%. In subgroup analysis TyG index\u2009\u2265\u200910 was associated with an increased risk in CS\u2009\u2265\u200970% in patients treated with statin or antiplatelet therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>More than one third of asymptomatic patients with type 2 diabetes had significant CS on CCTA. TyG index may be considered as a marker for insulin resistance and increased TyG index could identify patients with high risk of coronary artery stenoses and is associated with the number and the severity of artery stenoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-020-01108-2","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T09:02:38Z","timestamp":1599901358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes"],"prefix":"10.1186","volume":"19","author":[{"given":"Pham Viet","family":"Thai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Anh","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh","family":"Van Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"key":"1108_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, J\u00fcni P, Lettino M, Marx N, Mellbin LG, \u00d6stgren CJ, Rocca B, Roffi M, Sattar N, Seferovi\u0107 PM, Sousa-Uva M, Valensi P, Wheeler DC, ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2020;41:255\u2013323.","journal-title":"Eur Heart J"},{"key":"1108_CR2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","volume":"57","author":"SA Peters","year":"2014","unstructured":"Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57:1542\u201351.","journal-title":"Diabetologia"},{"key":"1108_CR3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1262-3636(07)70187-8","volume":"31","author":"E Cosson","year":"2005","unstructured":"Cosson E, Attali JR, Valensi P. Markers for silent myocardial ischemia in diabetes. Are they helpful? Diabetes Metab. 2005;31:205\u201313.","journal-title":"Diabetes Metab"},{"key":"1108_CR4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2337\/diacare.24.2.339","volume":"24","author":"P Valensi","year":"2001","unstructured":"Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care. 2001;24:339\u201343.","journal-title":"Diabetes Care"},{"key":"1108_CR5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/dme.13364","volume":"34","author":"A Sultan","year":"2017","unstructured":"Sultan A, Perriard F, Macioce V, Mariano-Goulart D, Boegner C, Daures JP, Avignon A. Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study. Diabet Med. 2017;34:1244\u201351.","journal-title":"Diabet Med"},{"key":"1108_CR6","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1001\/jama.2014.15825","volume":"312","author":"JB Muhlestein","year":"2014","unstructured":"Muhlestein JB, Lapp\u00e9 DL, Lima JA, Rosen BD, May HT, Knight S, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA. 2014;312:2234\u201343.","journal-title":"JAMA"},{"key":"1108_CR7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12944-016-0324-2","volume":"15","author":"EY Lee","year":"2016","unstructured":"Lee EY, Yang HK, Lee J, Kang B, Yang Y, Lee SH, et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016;15:155.","journal-title":"Lipids Health Dis"},{"key":"1108_CR8","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","volume":"25","author":"E Bonora","year":"2002","unstructured":"Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002;25:1135\u201341.","journal-title":"Diabetes Care"},{"key":"1108_CR9","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.25.7.1177","volume":"25","author":"AJ Hanley","year":"2002","unstructured":"Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care. 2002;25:1177\u201384.","journal-title":"Diabetes Care"},{"key":"1108_CR10","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jacc.2007.01.088","volume":"49","author":"J Jeppesen","year":"2007","unstructured":"Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007;49:2112\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1108_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4239\/wjd.v10.i2.63","volume":"10","author":"MM Adeva-Andany","year":"2019","unstructured":"Adeva-Andany MM, Ameneiros-Rodr\u00edguez E, Fern\u00e1ndez-Fern\u00e1ndez C, Dom\u00ednguez-Montero A, Funcasta-Calder\u00f3n R. Insulin resistance is associated with subclinical vascular disease in humans. World J Diabetes. 2019;10:63\u201377.","journal-title":"World J Diabetes"},{"key":"1108_CR12","first-page":"627","volume":"20","author":"E Bonora","year":"1997","unstructured":"Bonora E, Tessari R, Micciolo R, et al. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance Diabetes Care. 1997;20:627\u201331.","journal-title":"Relationship with insulin resistance Diabetes Care"},{"key":"1108_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299\u2013304.","journal-title":"Metab Syndr Relat Disord"},{"key":"1108_CR14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13098-018-0376-8","volume":"10","author":"SH Khan","year":"2018","unstructured":"Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10:74.","journal-title":"Diabetol Metab Syndr"},{"key":"1108_CR15","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","volume":"95","author":"F Guerrero-Romero","year":"2010","unstructured":"Guerrero-Romero F, Simental-Mend\u00eda LE, Gonz\u00e1lez-Ortiz M, Mart\u00ednez-Abundis E, Ramos-Zavala MG, Hern\u00e1ndez-Gonz\u00e1lez SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3347\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"1108_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/eci.12583","volume":"46","author":"L S\u00e1nchez-\u00cd\u00f1igo","year":"2016","unstructured":"S\u00e1nchez-\u00cd\u00f1igo L, Navarro-Gonz\u00e1lez D, Fern\u00e1ndez-Montero A, Pastrana-Delgado J, Mart\u00ednez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46:189\u201397.","journal-title":"Eur J Clin Invest"},{"key":"1108_CR17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.hlc.2017.05.142","volume":"27","author":"I Lambrinoudaki","year":"2018","unstructured":"Lambrinoudaki I, Kazani MV, Armeni E, Georgiopoulos G, Tampakis K, Rizos D, et al. The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Heart Lung Circ. 2018;27:716\u201324.","journal-title":"Heart Lung Circ"},{"key":"1108_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12944-020-1187-0","volume":"19","author":"GM Park","year":"2020","unstructured":"Park GM, Cho YR, Won KB, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020;19:7.","journal-title":"Lipids Health Dis"},{"key":"1108_CR19","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41598-019-42700-1","volume":"9","author":"YR Cho","year":"2019","unstructured":"Cho YR, Ann SH, Won KB, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Sci Rep. 2019;9:6129.","journal-title":"Sci Rep"},{"key":"1108_CR20","first-page":"A86","volume":"5","author":"H Van Minh","year":"2008","unstructured":"Van Minh H, Ng N, Juvekar S, Razzaque A, Ashraf A, Hadi A, et al. Self-reported prevalence of chronic diseases and their relation to selected sociodemographic variables: a study in INDEPTH Asian sites, 2005. Prev Chronic Dis. 2008;5:A86.","journal-title":"Prev Chronic Dis"},{"issue":"Suppl 1","key":"1108_CR21","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13\u2013S28.","journal-title":"Diabetes Care"},{"key":"1108_CR22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"1108_CR23","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u2013421.","journal-title":"Circulation"},{"key":"1108_CR24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcct.2014.07.003","volume":"8","author":"J Leipsic","year":"2014","unstructured":"Leipsic J, Abbara S, Achenbach S, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014;8:342\u201358.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"1108_CR25","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","volume":"93","author":"AC Vasques","year":"2011","unstructured":"Vasques AC, Novaes FS, de Oliveira MS, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93:e98\u2013e100.","journal-title":"Diabetes Res Clin Pract"},{"key":"1108_CR26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12933-017-0589-4","volume":"16","author":"MK Kim","year":"2017","unstructured":"Kim MK, Ahn CW, Kang S, Nam JS, Kim KR, Park JS. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16:108.","journal-title":"Cardiovasc Diabetol"},{"key":"1108_CR27","doi-asserted-by":"crossref","first-page":"e3646","DOI":"10.1097\/MD.0000000000003646","volume":"95","author":"D Navarro-Gonz\u00e1lez","year":"2016","unstructured":"Navarro-Gonz\u00e1lez D, S\u00e1nchez-\u00cd\u00f1igo L, Fern\u00e1ndez-Montero A, Pastrana-Delgado J, Martinez JA. TyG index change is more determinant for forecasting type 2 diabetes onset than weight gain. Medicine. 2016;95:e3646.","journal-title":"Medicine"},{"key":"1108_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12933-017-0514-x","volume":"16","author":"M Zhang","year":"2017","unstructured":"Zhang M, Wang B, Liu Y, Sun X, Luo X, Wang C, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the Rural Chinese Cohort Study. Cardiovasc Diabetol. 2017;16:30.","journal-title":"Cardiovasc Diabetol"},{"key":"1108_CR29","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00125-019-4921-2","volume":"6","author":"A Brahimaj","year":"2019","unstructured":"Brahimaj A, Rivadeneira F, Muka T, Sijbrands EJG, Franco OH, Dehghan A, Kavousi M. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;6:1581\u201390.","journal-title":"Diabetologia"},{"key":"1108_CR30","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.21037\/jtd.2018.10.79","volume":"10","author":"JL Jin","year":"2018","unstructured":"Jin JL, Cao YX, Wu LG, You XD, Guo YL, Wu NQ, et al. Triglyceride glucose index for predicting cardiovascular outcomes in patients with coronary artery disease. J Thorac Dis. 2018;10:6137\u201346.","journal-title":"J Thorac Dis"},{"key":"1108_CR31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/07853890.2018.1523549","volume":"50","author":"JL Jin","year":"2018","unstructured":"Jin JL, Sun D, Cao YX, Guo YL, Wu NQ, Zhu CG, et al. Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study. Ann Med. 2018;50:576\u201386.","journal-title":"Ann Med"},{"key":"1108_CR32","first-page":"6891537","volume":"2019","author":"Q Mao","year":"2019","unstructured":"Mao Q, Zhou D, Li Y, Wang Y, Xu SC, Zhao XH. The triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome. Dis Markers. 2019;2019:6891537.","journal-title":"Dis Markers"},{"key":"1108_CR33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-019-0957-3","volume":"18","author":"E Luo","year":"2019","unstructured":"Luo E, Wang D, Yan G, Qiao Y, Liu B, Hou J, Tang C. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovasc Diabetol. 2019;18:150.","journal-title":"Cardiovasc Diabetol"},{"key":"1108_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/ijcp.12124","volume":"67","author":"C Irace","year":"2013","unstructured":"Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, Gnasso A. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67:665\u201372.","journal-title":"Int J Clin Pract"},{"key":"1108_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-018-0692-1","volume":"17","author":"SB Lee","year":"2018","unstructured":"Lee SB, Ahn CW, Lee BK, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17:41.","journal-title":"Cardiovasc Diabetol"},{"key":"1108_CR36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12944-018-0914-2","volume":"17","author":"KB Won","year":"2018","unstructured":"Won KB, Park GM, Lee SE, et al. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17:268.","journal-title":"Lipids Health Dis"},{"key":"1108_CR37","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2337\/dc18-1920","volume":"42","author":"K Park","year":"2019","unstructured":"Park K, Ahn CW, Lee SB, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42:1569\u201373.","journal-title":"Diabetes Care"},{"key":"1108_CR38","doi-asserted-by":"crossref","first-page":"e108998","DOI":"10.1371\/journal.pone.0108998","volume":"9","author":"HL Nguyen","year":"2014","unstructured":"Nguyen HL, Nguyen QN, Ha DA, Phan DT, Nguyen NH, Goldberg RJ. Prevalence of comorbidities and their impact on hospital management and short-term outcomes in Vietnamese patients hospitalized with a first acute myocardial infarction. PLoS ONE. 2014;9:e108998.","journal-title":"PLoS ONE"},{"key":"1108_CR39","doi-asserted-by":"crossref","first-page":"e017008","DOI":"10.1136\/bmjopen-2017-017008","volume":"7","author":"T Nguyen","year":"2017","unstructured":"Nguyen T, Le KK, Cao HTK, Tran DTT, Ho LM, Thai TND, et al. Association between in-hospital guideline adherence and postdischarge major adverse outcomes of patients with acute coronary syndrome in Vietnam: a prospective cohort study. BMJ Open. 2017;7:e017008.","journal-title":"BMJ Open"},{"issue":"2_suppl","key":"1108_CR40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/2047487319885456","volume":"26","author":"P Valensi","year":"2019","unstructured":"Valensi P, Pr\u00e9vost G, Schnell O, Standl E, Ceriello A. Targets for blood glucose: what have the trials told us. Eur J Prev Cardiol. 2019;26(2_suppl):64\u201372.","journal-title":"Eur J Prev Cardiol"},{"key":"1108_CR41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/eurheartj\/ehaa078","volume":"41","author":"PR Lawler","year":"2020","unstructured":"Lawler PR, Kotri G, Koh M, et al. Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies. Eur Heart J. 2020;41:86\u201394.","journal-title":"Eur Heart J"},{"key":"1108_CR42","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","volume":"307","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307:1302\u20139.","journal-title":"JAMA"},{"key":"1108_CR43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2840-13-26","volume":"13","author":"JC Fruchart","year":"2014","unstructured":"Fruchart JC, Davignon J, Hermans MP, et al. Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol. 2014;13:26.","journal-title":"Cardiovasc Diabetol"},{"key":"1108_CR44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12933-016-0415-4","volume":"15","author":"P Valensi","year":"2016","unstructured":"Valensi P, Avignon A, Sultan A, Chanu B, Nguyen MT, Cosson E. Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2016;15:104.","journal-title":"Cardiovasc Diabetol"},{"key":"1108_CR45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","volume":"27","author":"J Bor\u00e9n","year":"2016","unstructured":"Bor\u00e9n J, Williams KJ. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27:473\u201383.","journal-title":"Curr Opin Lipidol"},{"key":"1108_CR46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111\u201388.","journal-title":"Eur Heart J"},{"key":"1108_CR47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.amjcard.2016.04.004","volume":"118","author":"M Budoff","year":"2016","unstructured":"Budoff M. Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease. Am J Cardiol. 2016;118:138\u201345.","journal-title":"Am J Cardiol"},{"key":"1108_CR48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MED.0000000000000398","volume":"25","author":"MP Hermans","year":"2018","unstructured":"Hermans MP, Valensi P. Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2018;25:118\u201329.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1108_CR49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","volume":"380","author":"DL Bhatt","year":"2019","unstructured":"Bhatt DL, Steg PG, Miller M, for the REDUCE-IT Investigators, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380:11\u201322.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-020-01108-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T19:08:22Z","timestamp":1631387302000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-020-01108-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1186\/s12933-020-01108-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-18846\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-18846\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"29 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by our institution\u2019s ethics committee, and informed consent for the procedure was obtained from each participant.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}